NEW YORK (GenomeWeb News) – Interleukin Genetics has received clearance in the State of New York to offer its genetic test for risk of periodontal disease, the company said today.

The State of New York's Department of Health approved the firm's PST Genetic Test through its Clinical Laboratory Evaluation Program, which monitors the accuracy and reliability of the results of lab tests and specimens obtained within the state.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.